Lymphocytes were gated on human CD45+ cells and histograms depicting CD38 expression between the two treatment conditions clearly demonstrate a significant decrease in CD38 expression in the residual tumor cells exposed to αCD38 antibody, whereas those in the IgG isotype condition retained their robust CD38 expression (Fig. 2C). This evidence concerns the gene CD38 and neoplasm.